Mechanisms of Electroacupuncture for Functional Dyspepsia Based on "Enterotypes" and Metabolomics
NCT05920395 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130
Last updated 2023-06-27
Summary
The goal of this clinical trial is to explore the clinical efficacy and possible mechanisms of electroacupuncture treatment for functional dyspepsia (FD). The main question it aims to answer are:
* Differences in the effects of electroacupuncture and sham electroacupuncture intervention on FD.
* Differences in gastrointestinal hormone levels and gut microbiota and their metabolites between healthy individuals and FD patients.
Participants receive electroacupuncture and sham electroacupuncture interventions respectively. Before and after the intervention, the clinical symptom score, gastrointestinal symptom evaluation scale, gastrointestinal symptom score questionnaire, and functional dyspepsia quality of life scale of the subjects will be observed. The levels of gastrointestinal hormones MTL, Ghrelin, 5-HT, CCK, PYY, and GLP-1 will be measured, as well as the changes in microbial diversity and SCFAs in their metabolites in feces, A follow-up visit will be conducted one month after the intervention for all participants.
Conditions
- Functional Dyspepsia
Interventions
- OTHER
-
Electro-acupuncture
Patients lie supine on the treatment bed, and after routine disinfection, a 0.30×60mm or 0.30×40mm disposable sterile acupuncture needle is inserted directly into the acupoint. Once obtaining qi, the needle is manipulated with even reinforcing and reducing techniques to maintain needle sensation. Acupoints selected include Zhongwan, Zusanli, Neiguan, and Tianshu, connected to the 6805-All electro-acupuncture therapy device. Zhongtuo and Tianshu acupoints are connected to a set of electrodes, with the positive pole connected to Zhongtuo and the negative pole connected to one side of Tianshu. The stimulation uses sparse and dense wave pulses with a frequency of 2Hz/100Hz, with the stimulation intensity determined based on individual patient tolerance. Each session lasts for 30 minutes, with a treatment frequency of once every other day, for a total of 4 weeks.
- OTHER
-
Sham electro-acupuncture group
Shallow acupuncture needles are used and then disconnected from the electrode. They are tied with black tape and connected to the sham electrode. The device is not powered on, and the rest of the treatment is the same as the electro-acupuncture group.
Sponsors & Collaborators
-
Wuhan Central Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-07-01
- Primary Completion
- 2024-06-30
- Completion
- 2024-12-31
More Related Trials
-
Effect of Acupuncture on Patients With Functional Dyspepsia: a Multi-center, Randomized, Waitlist-controlled Trial
NCT01921504 ·Status: UNKNOWN ·Phase: NA
-
Treatment of Functional Dyspepsia With Acupuncture
NCT00786214 ·Status: COMPLETED ·Phase: NA
-
Effect and Mechanism of Auricular Acupressure on Functional Dyspepsia With Insomnia
NCT06466044 ·Status: COMPLETED ·Phase: NA
-
Preliminarily Evaluate the Efficacy of Domperidone in Adult Chinese Participants With Functional Dyspepsia
NCT03617016 ·Status: COMPLETED ·Phase: PHASE4
-
International Clinical Study of Zhizhu Kuanzhong Capsule
NCT03825692 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Course of Functional Dyspepsia and Factors Predicting Outcome in Patients Receiving Medication-based Treatment
NCT05513040 ·Status: RECRUITING
-
Association of Functional Dyspepsia Symptom Diary Score and Other Scores Related to Functional Dyspepsia and Its Severity
NCT04953975 ·Status: COMPLETED
-
Analysis of Gastrointestinal Symptoms of Outpatients With Functional Gastrointestinal Diseases(FGIDs) in Grade-A Tertiary Hospitals in China
NCT04225559 ·Status: UNKNOWN
-
Safety Study of a Chinese Herbal Formula Simotang Oral Liquid for the Treatment of Functional Dyspepsia
NCT01232114 ·Status: UNKNOWN
-
Elucidating Mechanisms That Underlie the Symptomatology of Functional Dyspepsia Using Novel Techniques and Its Therapeutic Validation Using Neuromodulators
NCT06213948 ·Status: RECRUITING ·Phase: PHASE1
-
Changes in Etomidate Dosage in Insomnia Patients Undergoing Digestive Endoscopy
NCT07028177 ·Status: RECRUITING
-
Acupuncture Treatment for Gastroparesis: a Pilot Study
NCT01643577 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment of Functional Dyspepsia With Genuine Regional Rhizoma Atractylodis
NCT03173183 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Gut-Brain Neuromodulators for Functional Dyspepsia
NCT06931223 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia
NCT00358410 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Gastrogenic Microbiota in FD
NCT06760897 ·Status: COMPLETED ·Phase: NA
-
Study on the Rule and Mechanism of Treating Functional Gastrointestinal Diseases From the Perspective of Liver and Spleen
NCT04454996 ·Status: UNKNOWN ·Phase: PHASE4
-
Functional Dyspepsia Microbiome Study
NCT02340312 ·Status: COMPLETED
-
Abdominothoracic Muscular Tone in Functional Dyspepsia
NCT05417204 ·Status: COMPLETED ·Phase: NA
-
AutoSTEA for Adults With Functional Dyspepsia
NCT07020416 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Effects of Exercise on Functional Dyspepsia Based on Rome IV
NCT04540549 ·Status: UNKNOWN ·Phase: NA
-
Impact of Stigma on Compliance to Medication in Functional Dyspepsia
NCT03625674 ·Status: UNKNOWN ·Phase: NA
-
Tradipitant for Functional Dyspepsia
NCT05653310 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
A Multicenter Survey of the Indications for Esophagogastroduodenoscopy (EGD)
NCT03603093 ·Status: COMPLETED
-
To Observe the Clinical Efficacy of Traditional Chinese Medicine Compound(Weipi Formula ) in the Treatment of Epigastric Stuffiness Syndrome
NCT06985524 ·Status: ENROLLING_BY_INVITATION ·Phase: NA